TKTL2 Antikörper (C-Term)
Kurzübersicht für TKTL2 Antikörper (C-Term) (ABIN629780)
Target
Alle TKTL2 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- C-Term
-
Spezifität
- TKTL2 antibody was raised against the C terminal of TKTL2
-
Aufreinigung
- Purified
-
Immunogen
- TKTL2 antibody was raised using the C terminal of TKTL2 corresponding to a region with amino acids SSAKATGGRVITVEDHYREGGIGEAVCAAVSREPDILVHQLAVSGVPQRG
-
-
-
-
Applikationshinweise
-
WB: 2.5 µg/mL
Optimal conditions should be determined by the investigator. -
Kommentare
-
TKTL2 Blocking Peptide, catalog no. 33R-8786, is also available for use as a blocking control in assays to test for specificity of this TKTL2 antibody
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of TKTL2 antibody in PBS
-
Konzentration
- Lot specific
-
Buffer
- PBS
-
Handhabung
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- TKTL2 (Transketolase-Like 2 (TKTL2))
-
Andere Bezeichnung
- TKTL2
-
Hintergrund
- TKTL2 plays an essential role in total transketolase activity and cell proliferation in cancer cells. After transfection with anti-TKTL1 siRNA, total transketolase activity dramatically decreases and proliferation was significantly inhibited in cancer cells. TKTL2 may also play a pivotal role in carcinogenesis
-
Molekulargewicht
- 68 kDa (MW of target protein)
Target
-